The influence of gestational weight gain after bariatric procedures on selected pregnancy outcomes: a single center

Maciej Walędziak1, Joanna Kacperczyk-Bartnik2, Paweł Bartnik2

  • 1Department of General, Oncological, Metabolic and Thoracic Surgery, Military Institute of Medicine, Szaserów 128 St., Warsaw, Poland. maciej.waledziak@gmail.com.

Scientific Reports
|October 27, 2021
PubMed

Insights

Gestational weight gain percentage predicts large for gestational age infants and NICU admissions in bariatric surgery patients. Pre-pregnancy anemia is linked to higher gestational weight gain.

Area of Science:

  • Obstetrics and Gynecology
  • Bariatric Surgery Outcomes
  • Maternal-Fetal Medicine

Background:

  • Pregnancy post-bariatric surgery carries risks like small for gestational age infants and maternal anemia.
  • Understanding factors influencing pregnancy outcomes in this population is crucial.

Purpose of the Study:

  • To investigate the relationship between gestational weight gain (GWG%), maternal anemia, and infant outcomes in patients with a history of bariatric surgery.
  • To identify predictors of adverse neonatal outcomes such as large for gestational age (LGA) infants and neonatal intensive care unit (NICU) admission.

Main Methods:

  • Retrospective analysis of 71 patients with a history of bariatric surgery and at least one delivery post-surgery.
  • Key endpoints included GWG as a percentage of pre-pregnancy weight (GWG%), maternal anemia, SGA, LGA, and NICU admission.

Main Results:

  • Higher GWG% was observed in LGA infants (23.8%) compared to normal weight neonates (13.9%).
  • Patients with pre-pregnancy anemia exhibited higher GWG% (20.1%) than those without (13.4%).
  • GWG% was significantly higher in patients whose infants required NICU admission (25.3%) versus those who did not (14.1%).

Conclusions:

  • Gestational weight gain percentage (GWG%) is a potential risk predictor for LGA infants and NICU admissions in bariatric surgery patients.
  • Pre-pregnancy anemia is associated with increased GWG% in this cohort.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
19
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
200